Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
JAMA. 1993 Mar 10;269(10):1268-71.

A double-blind trial of a nicotine inhaler for smoking cessation.

Author information

  • 1Department of Pulmonary Medicine, Bispebjerg Hospital, Copenhagen, Denmark.

Abstract

OBJECTIVE:

To evaluate the efficacy of a new nicotine inhaler system for smoking cessation.

DESIGN:

A 1-year, randomized, double-blind, placebo-controlled study.

SETTING:

Medical outpatient clinic with physicians experienced in smoking cessation assistance.

SUBJECTS:

A total of 286 volunteers who smoked at least 10 cigarettes daily recruited through a local newspaper.

INTERVENTION:

Subjects were randomly allocated to nicotine inhalers (n = 145) or placebo (n = 141) to be used for 3 months followed by tapering for 3 months in the context of minimal levels of advice and support.

MAIN OUTCOME MEASURE:

Continuous smoking abstinence at weeks 6, 12, 24, and 52, verified by measurements of carbon monoxide in expired air.

RESULTS:

Continuous smoking abstinence was significantly higher for the active nicotine inhaler group compared with the placebo inhaler group. The respective success rates were 28% and 12% after 6 weeks, 21% and 9% after 12 weeks, 17% and 8% after 6 months, and 15% and 5% after 1 year (P = .02 to .001). The mean nicotine substitution based on cotinine determinations after 2 weeks was 43% (SD, 45%) of smoking levels. The treatment was well tolerated, and no serious adverse events were reported.

CONCLUSIONS:

In this setting the nicotine inhaler appeared safe to use and increased success rates of smoking cessation attempts.

Comment in

PMID:
8437304
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk